Obesity Care in Maryland
Can Obesity Cause Cancer? Understanding the Types and Risks
Keeping a healthy weight is essential for long-term wellness. Extra weight doesn’t just affect appearance—it significantly raises the risk of diseases, including cancer. Obesity, defined by excessive body fat, goes beyond aesthetic concerns and plays a role in making the body more susceptible to certain cancers.
Published
Retatrutide: A Promising Breakthrough for Fatty Liver Disease
Fatty liver disease has become a global health crisis, affecting millions worldwide. Now called metabolic dysfunction-associated steatotic liver disease (MASLD), its prevalence has skyrocketed due to rising obesity rates. Retatrutide, a triple hormone receptor agonist, is showing a game-changing potential in reducing liver fat and improving metabolic health.
Published
GLP-1: A Surprising Friend Against Cancer in Type 2 Diabetes?
New research suggests diabetes drugs known as GLP-1 receptor agonists (GLP-1) might protect against certain cancers. This study focused on type 2 diabetes patients and followed them for 15 years. It’s a surprising finding that could change cancer prevention for diabetes patients.
Published
Semaglutide’s Double Power for Weight Loss and Knee Pain
The study, Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis, explores the impact of weekly semaglutide injections. It focuses on weight loss and pain relief for people with obesity and knee osteoarthritis (OA)
Published
Tirzepatide: A Double Approach to Diabetes and Weight Loss
Tirzepatide is a groundbreaking therapy gaining attention for treating type 2 diabetes and obesity. Unlike traditional drugs that target one pathway, tirzepatide uses two hormones, GLP-1 and GIP, to achieve a fuller metabolic control.
Published
Categorized as Diabetes Care, GLP1 agonist, Insights from Dr. Tashko, Tirzepatide Patient Information, Weight Loss
Eating Smart on GLP-1: 10 Strategies for Successful Weight Loss
The GLP-1 medications—like tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy)—have become powerful allies in weight loss. They work by reducing appetite, enhancing insulin response, and supporting a balanced metabolism. But to make the most of these treatments, eating smart is essential.
Published
Categorized as GLP1 agonist, Insights from Dr. Tashko, Insulin Resistance, Nutritional Guidance, Obesity Care, Weight Loss